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Abstract
Studies on inflammatory disorders elucidated the pivotal role of the CX3CL1/CX3CR1 axis with
respect to the pathophysiology and diseases progression. Coxsackievirus B3 (CVB3)-induced
myocarditis is associated with severe cardiac inflammation, which may progress to heart fail-
ure. We therefore investigated the influence of CX3CR1 ablation in the model of acute myocar-
ditis, which was induced by inoculation with 5x105 plaque forming units of CVB3 (Nancy strain)
in either CX3CR1-/- or C57BL6/j (WT) mice. Seven days after infection, myocardial inflamma-
tion, remodeling, and titin expression and phosphorylation were examined by immunohis-
tochemistry, real-time PCR and Pro-Q diamond stain. Cardiac function was assessed by tip
catheter. Compared to WT CVB3 mice, CX3CR1-/- CVB3 mice exhibited enhanced left ventric-
ular expression of inflammatory cytokines and chemokines, which was associated with an
increase of immune cell infiltration/presence. This shift towards a pro-inflammatory immune
response further resulted in increased cardiac fibrosis and cardiomyocyte apoptosis, which
was reflected by an impaired cardiac function in CX3CR1-/- CVB3 compared to WT CVB3
mice. These findings demonstrate a cardioprotective role of CX3CR1 in CVB3-infected mice
and indicate the relevance of the CX3CL1/CX3CR1 system in CVB3-induced myocarditis.
Introduction
Viral myocarditis is a cardiac disorder characterized by cardiac inflammation, which is often
caused by cardiotropic viruses like Coxsackievirus group B type 3 (CVB3) and can progress to
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dilated cardiomyopathy (DCM) and congestive heart failure [1]. With respect to CVB3, a
direct cardiomyocyte injury and subsequent long-term inflammatory reaction belong to the
discussed mechanisms involved in the CVB3-induced pathogenesis [2,3]. However, the exact
pathogenesis of CVB3-induced myocarditis needs still a better understanding [4] to find effi-
cient therapeutic options counteracting the virus-induced inflammatory response [5].
Chemokine-induced migration of inflammatory cells plays a crucial role during cardiac
inflammation [6–8]. Among the chemokine super-family, fractalkine (CX3CL1) exists in two
distinct forms. The membrane-bound form serves as an adhesion protein. The soluble mole-
cule has chemoattractant properties and is proteolytically cleaved from the cell membrane-
anchored form of fractalkine [9,10]. Cellular sources of CX3CL1 include endothelial cells, epi-
thelial cells, dendritic cells, macrophages and cardiomyocytes [9,11]. Both chemotaxis and
adhesion are mediated by the G-protein-coupled receptor CX3CR1 [12], which is mainly
expressed on natural killer cells, some T cell populations, dendritic cells and monocytes [10].
Interestingly, soluble CX3CL1 attracts natural killer cells, T cells, and dendritic cells and inhib-
its the function of the monocyte chemoattractant protein-1 (MCP-1) [10,13].
In previous studies, the CX3CL1/CX3CR1 system has been shown to be involved in the
pathophysiology of cardiovascular disorders including heart failure [14,15] and inflammatory
cardiomyopathy [9]. CX3CL1/CX3CR1 is also of relevance in the pathogenesis of other inflam-
matory disorders such as glomerulonephritis [16], rheumatoid arthritis [17] and cardiac allo-
graft rejection [18]. Fractalkine and its receptor CX3CR1 have been shown to exert
detrimental effects, since neutralization of the chemokine improved cardiac function after
myocardial infarction [19] and inhibition of the respective receptor reduced atherosclerosis in
mice [20]. Besides these findings, there are also data indicating a protective role of CX3CR1
since the loss of this receptor results in higher liver fibrosis in a model of hepatic fibrosis [21]
and increased accumulation of inflammatory monocytes in gliomagenesis [22]. Abovemen-
tioned findings indicate the complexity of the CX3CL1/CX3CR1 system.
Since CX3CR1 is involved in inflammatory disorders, cardiovascular diseases and viral
infection, and due to the lack of data regarding the role of CX3CR1 in viral experimental myo-
carditis, we aimed to investigate the pathophysiological role of CX3CR1 in experimental
CVB3-induced acute myocarditis.
Materials and methods
Induction of myocarditis and hemodynamic measurements
Six week-old male C57BL6/j mice (further named as WT; provided by the Forschungseinrich-
tung fu¨r experimentelle Medizin (FEM), Berlin, Germany) and CX3CR1 deficient mice (further
named as CX3CR1-/-, provided by I. Hamann and C. Infante-Duarte [23]) were randomly
divided into 4 groups (n = 7–12 per group). The experimental groups consisted of WT, WT
CVB3, CX3CR1-/-, and CX3CR1-/- CVB3. Mice were either treated with 5×105 plaque forming
units of CVB3 (Nancy strain) or with saline. One week after infection, all animals were anesthe-
tized (Urethane 0.8–1.2 g/kg i.p., Sigma, Germany; Buprenorphin 0.05 mg/kg i.p. Essex Pharma,
Germany), intubated, and artificially ventilated with a rodent ventilator type 7025 (Ugo Basile,
Comerio VA, Italy). Via a tip catheter (1.2F) system, indices of systolic and diastolic left ventricu-
lar function were recorded as described previously [2,24]. After determination of the cardiac
function, mice were euthanized by cervical dislocation and the left ventricle (LV) and spleen
were excised, immediately snap frozen in liquid nitrogen and stored at -80˚C for molecular biol-
ogy and immunohistological analyses. This investigation conforms to the European principles of
laboratory animal care (Directive 2010/63/EU) and was approved by the local ethical committee
(Landesamt fu¨r Gesundheit und Soziales, Berlin, Nr: G0313/09). Mice were kept under standard
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conditions (1212 h light-dark cycle, 20–24˚C), with unlimited access to water and food. After
CVB3 infection, mice were daily monitored and scored according the following criteria: 0 = no
disease; 1 = weight loss; 2 = reduced activity; 3 = apathy and severe signs of heart failure.
RNA isolation, cDNA synthesis and gene expression analysis
For total RNA isolation from murine tissue, the TRIzol1 (Life Technologies GmbH, Darm-
stadt, Germany) method was used followed by cDNA synthesis with the High Capacity Kit
(Life Technologies GmbH). To assess the relative mRNA expression of the target genes in
murine LVs and spleens, real-time PCR was performed on a QuantStudioTM 6 Flex (Life
Technologies) using gene expression assays from Life Technologies (Table 1). All data were
normalized to the housekeeping genes 18S as endogenous controls (Table 1) and are expressed
using the 2-ΔCt formula followed by a normalization to the WT group, which was set as 1.
CVB3 mRNA expression was detected using the forward primer and the reverse primer at a
final concentration of 60 ng/μl and a FAM-labelled MGB probe at a final concentration of 5
pM (TIB Molbiol, Berlin Germany; Table 1).
Immunohistological measurements
The obtained tissue samples of the LV were embedded in Tissue-Tek OCT compound (Sakura,
Zoeterwoude, Netherlands). Immunohistochemistry was performed with specific antibodies
directed against CX3CL1 (rabbit anti-CX3CL1, Abcam, Cambridge, United Kingdom), CD4
(rat anti-CD4, BD Biosciences, Heidelberg, Germany), CD3 (rat anti-CD3, BD Biosciences),
CD68 (rabbit anti-CD68, Abcam), ICAM-1 (armenian hamster anti-ICAM-1, BD
Table 1. Reporter assays and primers.
Gene Assay number
Monocyte chemotactic Protein-1 MCP-1 Mm00441242_m1
C-C chemokine receptor type 2 CCR2 Mm00438270_m1
chemokine (C-X3-C motif) ligand 1 CX3CL1 Mm00436454_m1
chemokine (C-X3-C motif) receptor 1 CX3CR1 Mm02620111_s1
Ly6C Mm03009946_m1
intercellular cell adhesion molecular-1 ICAM-1 Mm00516023_m1
vascular cell adhesion molecular-1 VCAM-1 Mm01320970_m1
Tumor necrosis factor α TNF-α Mm00443258_m1
Interferon γ IFN-γ Mm00801778_m1
Interleukin 1β IL-1β Mm00434228_m1
Interleukin 6 IL-6 Mm00446190_m1
Endothelial Nitric Oxide Synthase iNOS Mm00440502_m1
Inducible Nitric Oxide Synthase eNOS Mm01164908_m1
NADPH oxidase 1 NOX1 Mm00549170_m1
NADPH oxidase 4 NOX4 Mm00479246_m1
Transforming growth factor β1 TGF-β1 Mm00441724_m1
Bax Mm00432050_m1
B-cell lymphoma 2 Bcl-2 Mm00477631_m1
Interferon β IFN-β Mm00439546_s1
Housekeeping gene 18s Hs99999901_s1
CVB3 forward primer 5´-CCCTGAATGCGGCTAATCC-3´m
CVB3 reverse primer 5´-ATTGTCACCATAAGCAGCCA-3´m
FAM-labeled MGB probe FAM 5´-TGCAGCGGAACCG-3
https://doi.org/10.1371/journal.pone.0182643.t001
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Biosciences), VCAM (rat anti-VCAM, BD Biosciences) collagen I (rabbit anti-Col I, Chemi-
con, Darmstadt, Germany), and collagen III (rabbit anti-Col III, Calbiochem, Darmstadt, Ger-
many). Quantification was performed by digital image analyses using a 200x magnification, as
described in detail elsewhere [25]. For the identification of specific CX3CL1-expressing cells,
stainings were performed on successive Tissue-Tek OCT embedded tissue samples by using
the CX3CL1 antibody as mentioned above and cell-specific markers including CD68 (rabbit
anti-CD68, Abcam), CD11b (rat anti-CD11b, BD Biosciences), Ly6g (rat anti-Ly6g, GeneTex,
Irvine, USA), CD4 (rat anti-CD4, BD Biosciences), CD8a (rat anti-CD8a, Biolegend), and
fibroblast-marker (rat anti-fibroblast, Santa Cruz, Heidelberg, Germany). Overall, congruent
areas were identified on the successive CX3CL1 and respective cell marker slides. Subse-
quently, digital images at a 200x magnification were taken for representative pictures.
All-titin phosphorylation by Pro-Q Diamond stain
The composition as well as the phosphorylation state of the cardiac titin isoform N2B was
determined using Pro-Q Diamond phospho-protein stain as described elsewhere [26]. To pre-
serve the endogenous phosphorylation state of the proteins, frozen tissues from LV mouse
hearts were solubilized and treated as described for titin isoform separation. The gels were
stained for 1 h with Pro-Q Diamond phosphoprotein stain. Fixation, washing and de-staining
were performed according to the manufacturer’s guidelines. To assess total protein content,
gels were stained overnight with SYPRO Ruby. Staining was visualized using the LAS-4000
Image Reader (460 nm/605 nm Ex/Em; 2 s illumination) and signals were analyzed with Multi
Gauge V3.2 and AIDA software.
Statistical analysis
Statistical analysis was performed using GraphPad Prism 5.0 software (GraphPad Software, La
Jolla, CA). Data are expressed as the mean ± SEM. Ordinary one-way ANOVA was performed
to compare parametric data, whereas non-parametric data were compared with Kruskal-Wal-
lis. Both analyses were followed by a post hoc test. Differences were considered statistically sig-
nificant at a value of p<0.05.
Results
Impact of CX3CR1-/- on chemokine receptor and chemokine expression
in Coxsackievirus B3-infected mice
Since the CX3CR1/CX3CL1 system is upregulated in inflammatory cardiomyopathy and has
chemotactic properties [9], we examined the impact of CX3CR1-/- on cardiac chemokine recep-
tor and chemokine expression in CVB3-induced myocarditis. LV CCR2 mRNA levels were
slightly upregulated in WT CVB3-infected mice versus control mice, which was accompanied
by a 41-fold (p<0.05) increase of LV MCP-1 levels (Fig 1A and 1B). Ablation of CX3CR1 led
to 4.1-fold (p<0.0001) and 2.6-fold (p<0.001) increased CCR2 and MCP-1 mRNA levels in
CX3CR1-/- CVB3 vs WT CVB3 mice, respectively (Fig 1A and 1B). LV CX3CR1 expression
was unaltered in WT CVB3-infected versus control mice (Fig 1C). Additionally, CX3CL1 gene
expression was 1.7-fold (p<0.0001) induced in WT CVB3 mice versus control mice (Fig 1D),
which was paralleled by a 17-fold (p<0.05) enhanced LV CX3CL1 protein expression in those
mice (Fig 1E). CX3CR1-/- CVB3 mice exhibited no significant changes of LV CX3CL1 gene and
protein levels versus WT CVB3 mice. Detailed analysis of LV CX3CL1 expression by immuno-
histochemistry demonstrated that CX3CL1 is expressed by infiltrated CD11b, CD68, Ly6g
+ cells, and cardiac fibroblasts, but not by CD4 and CD8 cells (S1 Fig).
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In parallel to the chemokine regulation in the LV, splenic CCR2, MCP-1, and CX3CR1
gene expression was 2.2-fold (p<0.05), 3.5-fold (p<0.001), and 1.6-fold (p<0.05) increased in
CVB3-infected compared to control mice, respectively (S2A-S2C Fig). CCR2 mRNA levels
were further 3.2-fold (p<0.05) enhanced in the spleen of CX3CR1-/- CVB3 vs WT CVB3 mice
(S2A Fig).
Fig 1. Impact of CX3CR1-/- on left ventricular chemokine receptor and chemokine expression in Coxsackievirus B3-infected
mice. Bar graphs represent the mean ± SEM of gene expression data of LV (A) CCR2, (B) MCP-1, (C) CX3CR1, and (D) CX3CL1, as
indicated, after normalization to the housekeeping gene 18S using the 2−ΔCt formula and normalized to the WT group, which was set
as 1. Quantitative CX3CL1 protein expression (E) was determined via digital image analysis at a 200x magnification (scale
bar = 200 μm). Bar graphs represent the mean ± SEM. Statistical analysis was performed by One-way ANOVA or the Kruskal-Wallis
test. *p<0.05, ***p<0.001, ****p<0.0001 with n = 7–12 per group.
https://doi.org/10.1371/journal.pone.0182643.g001
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Impact of CX3CR1-/- on cardiac inflammatory cell presence, adhesion
molecules, and cytokines in Coxsackievirus B3-infected mice
The upregulated LV MCP-1 expression in CX3CR1-/- CVB3 versus WT CVB3 mice was
accompanied by a 1.7-fold (p<0.05), 3.6-fold (p<0.01), 4.9-fold (p<0.01), and 2.8-fold
(p<0.01) increase of LV Ly6C mRNA levels and CD68+, CD3+ and CD4+ cells, respectively
(Fig 2). In parallel to the enhanced presence of inflammatory cells, CX3CR1-/- CVB3 animals
exhibited 1.4-fold (p<0.05) and 2.1-fold (p<0.01) increased expression levels of intercellular
adhesion molecular-1 (ICAM-1) and vascular cell adhesion molecular-1 (VCAM-1), respec-
tively (Fig 3A and 3B). The increased infiltration of immune cells in CX3CR1-/- CVB3 com-
pared to WT CVB3 mice was further reflected in 2.3-fold (p<0.01), 2.1-fold (p<0.05), 2.4-fold
(p<0.01) and 3.8-fold (p<0.001) higher mRNA expression of the CVB3-induced pro-inflam-
matory cytokines TNF-α, IFN-γ, IL-1β, and IL-6, respectively (Fig 3C–3F).
Impact of CX3CR1-/- on oxidative stress in Coxsackievirus B3-infected
mice
CX3CR1-/- CVB3 mice exhibited 1.4-fold (p<0.05) higher LV iNOS mRNA levels compared
to WT CVB3 mice (Fig 4A). In contrast, CX3CR1-/- CVB3 mice displayed 1.7-fold (p<0.01)
lower eNOS mRNA levels vs WT CVB3 mice (Fig 4B). Interestingly, neither NOX1 nor NOX4
mRNA levels were changed when comparing CX3CR1-/- CVB3 vs WT CVB3 mice (Fig 4C
and 4D).
Impact of CX3CR1-/- on cardiac fibrosis and titin phosphorylation in
Coxsackievirus B3-infected mice
Evaluation of the expression of the pro-fibrotic factor TGF-β1 [27] revealed that CX3CR1-/-
CVB3 mice displayed 1.5-fold (p<0.001) higher LV TGF-β1 mRNA levels versus WT CVB3
mice (Fig 5A). In agreement, the collagen I / III protein ratio was 2.4-fold (p<0.05) higher in
CX3CR1-/- CVB3 mice compared to WT CVB3 mice, indicating an elevated pathological colla-
gen deposition (Fig 5B). Since besides cardiac fibrosis also titin dysregulation [28] contributes to
left ventricular dysfunction, we next evaluated the impact of CX3CR1-/- on the titin N2B isoform
composition and phosphorylation state. CX3CR1-/- CVB3 mice exhibited 1.5-fold (p<0.05)
lower titin N2B expression levels compared to WT CVB3 mice (Fig 6A). Titin phosphorylation
was 1.6-fold (p<0.001) reduced in WT CVB3 compared to uninfected controls. A 1.4-fold
(p<0.05) decrease in titin phosphorylation was also present in CX3CR1-/- vs WT mice (Fig 6B).
Impact of CX3CR1-/- on cardiac apoptosis, IFN-β expression, and CVB3
presence in Coxsackievirus B3-infected mice
Since cardiomyocyte apoptosis is an important trigger for CVB3 viral progeny release [2], we
next analyzed the impact of CX3CR1-/- on a marker of cardiomyocyte apoptosis, the Bax/Blc2
ratio [29–32]. CX3CR1-/- CVB3 mice displayed a 2.1-fold (p<0.0001) higher Bax/Bcl2 ratio
compared to WT CVB3 mice (Fig 7A). In parallel to this enhanced ratio, the anti-viral cytokine
IFN-β [33] was 1.6-fold (p<0.001) increased in CX3CR1-/- CVB3 vs WT CVB3 mice (Fig 7B).
CX3CR1-/- CVB3 mice displayed 5.6-fold (p<0.05) higher CVB3 mRNA levels compared to
WT CVB3 mice (WT CVB3: 5.4x104 ± 1.0x104 (n = 8) vs CX3CR1-/- CVB3: 3.0x105 ± 8.5x104
(n = 10); p<0.05).
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Impact of CX3CR1-/- on hemodynamic function in Coxsackievirus
B3-infected mice
Given the impact of CX3CR1-/- on cardiac inflammation, fibrosis, N2B titin, and apoptosis in
CVB3-infected myocarditis mice, we next evaluated whether these effects were translated in
changes in left ventricular function. Hemodynamic characterization demonstrated that
CX3CR1-/- CVB3 mice exhibited an impaired systolic and diastolic function compared to WT
CVB3 mice as indicated by 19% (p<0.01), 25% (p<0.05) and 33% (p<0.05) impaired LVPmax,
dP/dtmax, and dP/dtmin, respectively (Fig 8).
Discussion
In the present study, we could demonstrate that CX3CR1 plays a critical role in the pathogene-
sis of CVB3-induced myocarditis. This follows from the findings that CX3CR1-/- CVB3 mice
exhibited an exacerbated CVB3-induced myocarditis as shown by a higher LV MCP-1 and
CCR2 expression, more cardiac infiltrates, and higher cytokine levels versus CVB3-infected
WT mice. In addition, cardiac fibrosis, apoptosis and CVB3 presence were more pronounced
and titin was dysregulated in CX3CR1-/- CVB3 mice compared to WT CVB3 mice.
Although the exact pathogenesis of CVB3-induced myocarditis is still a matter of debate
[4], chemokine-induced cardiac migration of inflammatory mononuclear cells is considered
to be the initial step [7]. Nevertheless, the role of the chemokine receptor CX3CR1 has not
been unraveled yet in experimental CVB3-induced myocarditis. Accumulating evidence dem-
onstrates that the CX3CL1/CX3CR1 axis plays a role in cardiac disorders. CVB3-positive
inflammatory cardiomyopathy patients showed induced CX3CL1 expression in endomyocar-
dial biopsies and increased CX3CR1 expression in peripheral blood mononuclear cells [9].
This finding encouraged us to examine the role of CX3CR1 in CVB3-induced myocarditis.
In agreement with the abovementioned findings in CVB3-positive inflammatory cardiomy-
opathy patients [9], we observed increased CX3CL1 mRNA and protein expression levels in
the LV of CVB3-infected versus control mice. Since CX3CL1 is expressed by CD68 and
CD11b monocytes/macrophages and cardiac fibroblasts (S1 Fig), the upregulation in LV
CX3CL1 expression in CVB3-infected mice can partly be explained by the increase in mono-
cytes/macrophages (Fig 2) and cardiac fibroblast presence (Fig 5) in myocarditis mice. Con-
form to the systemic increased CX3CR1 expression in peripheral blood mononuclear cells of
CVB3-positive inflammatory cardiomyopathy patients [9], an upregulation in CX3CR1
mRNA expression was found in the spleen of CVB3-infected myocarditis compared to control
mice. However, CX3CR1 LV mRNA levels were unchanged among CVB3 and control mice.
Furthermore, we showed an increased expression of the chemokine MCP-1 and its receptor
CCR2 in cardiac and splenic tissue of CVB3-induced myocarditis versus control mice. This is
in further harmony with the MCP-1 findings in EMBs and peripheral blood mononuclear cells
of CVB3-positive inflammatory cardiomyopathy patients [9]. Both MCP-1 and CCR2 play a
pivotal in the CVB3-induced myocarditis pathogenesis [7]. In addition, the expression of
Ly6C-positive monocytes was also increased in the LVs of CVB3-infected mice. Interestingly,
CX3CR1-/- CVB3 mice exhibited higher LV MCP-1 and CCR2 expression levels, but no
Fig 2. CX3CR1-/- induces left ventricular cell infiltration in Coxsackievirus B3-infected mice. (A,B) Gene
expression level of Ly6C and immunohistological staining of CD68+ cells as marker for monocyte infiltration (C,
D) Staining for CD3+ and CD4+ cells in the myocardium after CVB3-infection. The quantitative determination of
the immune staining was performed via digital image analysis at a 200x magnification (scale bar = 200 μm). Bar
graphs represent the mean ± SEM. Statistical analysis was performed by One-way ANOVA or the Kruskal-
Wallis test. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 with n = 7–12 per group.
https://doi.org/10.1371/journal.pone.0182643.g002
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further increase in LV CX3CL1 expression compared to WT CVB3 mice. Furthermore, the
increased LV MCP-1 and CCR-2 levels were also accompanied by enhanced Ly6C expression
and a higher presence of CD68 positive cells. The data concerning LV MCP-1 and Ly6C are
consistent with other findings where loss of CX3CR1 increased the accumulation of inflamma-
tory monocytes [22], whereas the expression of CCR2 and CD68 positive cells in CX3CR1-/-
mice has not been elucidated before. Additionally, we observed an induction of the adhesion
molecules VCAM-1 and ICAM-1 in the LV, which is in harmony with the increased levels of
MCP-1 and CCR2, which are triggers of these two adhesion molecules [34].
Basically, these observations suggest that under experimental CVB3 conditions, the infiltra-
tion of pro-inflammatory monocytes dominates over the invasion of anti-inflammatory
Fig 3. CX3CR1-/- enhances left ventricular expression of adhesion molecules and pro-inflammatory
cytokines in Coxsackievirus B3-infected mice. Induction of ICAM-1 (A) and VCAM-1 (B) as well as of pro-
inflammatory cytokines (C-F) in CX3CR1-/- mice compared to WT CVB3 mice. The quantitative determination
of ICAM-1 and VCAM-1, indicated by the positive area (%) in relation to the heart area (mm2), was performed
via digital image analysis at a 200x magnification (scale bar = 200 μm). Bar graphs represent the mean ± SEM.
Statistical analysis was performed by One-way ANOVA or the Kruskal-Wallis test. *p<0.05, **p<0.01,
***p<0.001, ****p<0.0001 with n = 7–12 per group.
https://doi.org/10.1371/journal.pone.0182643.g003
Fig 4. CX3CR1-/- displays increased left ventricular oxidative stress in Coxsackievirus B3-infected mice. Bar graphs
represent the mean ± SEM of gene expression data of LV (A) iNOS (B) eNOS, (C) NOX11, and (D) NOX4, as indicated, after
normalization to the housekeeping gene 18S using the 2−ΔCt formula and normalized to the WT group, which was set as 1. (A,B)
Gene expression analysis of NOS show differences between CX3CR1-/- CVB3 and WT CVB3 mice. Additional, no changes in
NOX mRNA expression between CX3CR1-/- CVB3 and WT CVB3 mice could be observed (C,D). Statistical analysis was
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Fig 5. CX3CR1-/- leads to enhancement of myocardial fibrosis in Coxsackievirus B3-infected mice. Bar graphs represent the
mean ± SEM of LV (A) TGF-ß1 gene expression, as indicated, after normalization to the housekeeping gene 18S using the 2−ΔCt
formula and normalized to the WT group, which was set as 1, and (B) collagen I/III ratio, demonstrated by immunohistological
stainings of (C) collagen I and (D) collagen III. Specific epitopes of collagen I and collagen III are coloured red as shown by
representative images (scale bar = 200 μm). Quantification of the positive area (%) / heart area (mm2) was performed via digital
image analysis. Statistical analysis was performed by One-way ANOVA or the Kruskal-Wallis test. *p<0.05, **p<0.01, ***p<0.001,
****p<0.0001 with n = 7–12 per group.
https://doi.org/10.1371/journal.pone.0182643.g005
Fig 6. CX3CR1-/- results in changes in titin isoform phosphorylation. (A) Expression of the N2B isoform and the
corresponding phosphorylation (B). The composition as well as the phosphorylation state of the cardiac titin isoform N2B was
determined using Pro-Q Diamond phospho-protein stain. In contrast to N2B phosphorylation the cardiac titin isoform composition
is different in CX3CR1-/- CVB3 mice to WT CVB3 mice, respectively. Bar graphs represent the mean ± SEM. Statistical analysis
was performed by One-way ANOVA or the Kruskal-Wallis test. *p<0.05, ***p<0.001 with n = 7–12 per group.
https://doi.org/10.1371/journal.pone.0182643.g006
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mononuclear cells, since it has been shown that the first subtype invades via the CCR2 and
MCP-1 pathway, whereas anti-inflammatory monocytes invade in a CX3CR1-dependent man-
ner [35,36]. Furthermore, CX3CR1 seems to control the CCR2/MCP-1-dependent pathway,
since CX3CR1 ablation resulted in an exacerbation of CVB3-induced myocarditis. This con-
trol mechanism was also postulated by Menasria [35].
In harmony with the increased inflammatory cell presence in CX3CR1-/- CVB3 versus WT
CVB3 mice, we demonstrated enhanced LV cytokine expression including IL-6, IL-1β, TNF-α
and IFN-γ in CX3CR1-/- CVB3 compared to WT CVB3 mice. This is in alignment with other
findings, where the loss of CX3CR1-/- led to enhanced IL-6, IL-1β, TNF-α, and IFN-γ levels
and where IL-1β is stated as a canonical inducer of MCP-1 [22,35]. Additionally, the enhanced
presence of CD3+ and CD4+ lymphocytes in CX3CR1-/- CVB3 mice may also account for the
enhanced inflammatory mediator levels.
Besides the detrimental CVB3-induced inflammatory effect, also oxidative stress leads to an
aggravation of myocardial injury [37] and thus exacerbates inflammation [38]. No changes
were found in the expression of NOX1 and NOX4, which comprise two of the seven NADPH
oxidases members [39] and are a major source of ROS [40]. However, iNOS and eNOS, the
two main members of the NO family synthases [41], were differently expressed in CX3CR1-/-
CVB3 mice compared to WT CVB3 animals: whereas eNOS was downregulated in CX3CR1-/-
Fig 7. CX3CR1-/- increases apoptosis and anti-viral cytokine expression in Coxsackievirus B3-infected mice. (A) The
Bax/Bcl-2 ratio as index for cardiomyocyte apoptosis indicates increased cardiomyocyte apoptosis in infected CX3CR1-/- mice
compared to the corresponding WT mice. (B) Gene expression of anti-viral IFN-β is increased in CX3CR1-/- CVB3 versus WT
CVB3 mice. Bar graphs represent the mean ± SEM. Statistical analysis was performed by One-way ANOVA or the Kruskal-Wallis
test. *p<0.05, ***p<0.001, ****p<0.0001 with n = 7–12 per group.
https://doi.org/10.1371/journal.pone.0182643.g007
Fig 8. CX3CR1-/- impaired left ventricular function in Coxsackievirus B3-infected mice. Evaluation of cardiac function via tip catheter. After
inoculation with CVB3 CX3CR1-/- mice show declined heart function as indicated by (A) reduced max. LV pressure (LVPmax), (B) reduced LV
contractility (dP/dtmax) and (C) decreased LV relaxation (dP/dtmin). Bar graphs represent the mean ± SEM. Statistical analysis was performed by
One-way ANOVA or the Kruskal-Wallis test. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 with n = 7–12 per group.
https://doi.org/10.1371/journal.pone.0182643.g008
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CVB3 versus WT CVB3 mice, iNOS expression was increased in those mice. This suggests a
higher oxidative stress in the LV of CVB3 mice deficient for CX3CR1 compared to WT CVB3
mice, which might underlie the increased viral presence in CX3CR1-/- CVB3 versus WT CVB3
mice since oxidative stress and subsequent cardiomyocyte apoptosis contribute to viral prog-
eny release [2]. Along with this hypothesis, the Bax/Bcl2 ratio, an important marker for cardio-
myocyte apoptosis as consistently shown by Spillmann et al. [29], Leri et al. [30,31], as well as
by Van Linthout et al. [32], was higher in CX3CR1-/- CVB3 mice compared to WT CVB3
mice.
The more pronounced cardiac fibrosis in CVB3-infected CX3CR1-/- versus CVB3 WT
mice, as reflected by an enhancement of pro-fibrotic TGF-β1 [27] and collagen I and III
expression, is in line with mouse CX3CR1-/- models of liver or kidney fibrosis [42,43]. Since
TGF-β is produced by infiltrating monocytes and T cells [44,45], these findings suggest that
the enhanced infiltration of monocytes and T cells in CX3CR1-/- CVB3 mice underlie the
raised expression of TGF-β, leading to more myofibroblasts and thus more collagen I and III
in CX3CR1-/- CVB3 versus WT CVB3 mice, further corroborating the link between cardiac
inflammation and cardiac fibrosis [27,46].
The giant myofilament titin influences cardiac contractility and relaxation [28]. Two main
titin isoforms exist: N2B and N2BA, of which among others impaired N2B phosphorylation
leads to cardiac dysfunction [26]. The present study revealed no changes between WT CVB3
and CX3CR1-/- CVB3 mice in the phosphorylation state of N2B, while we could demonstrate a
lower N2B titin isoform expression in CX3CR1-/- CVB3 mice. Mutations in the N2B isoform
have been shown to be associated with DCM and hypertrophic CM in humans [47], and tar-
geted deletion of the N2B region in mice resulted in diastolic dysfunction [48]. Based on these
data, we assume that besides the accumulation of collagens, the lower N2B isoform expression
might explain the reduced cardiac function, as displayed by a reduction of the systolic and dia-
stolic parameters dP/dtmax, and dP/dtmin in CX3CR1
-/- mice compared to the WT infected ani-
mals. A further explanation for the impaired cardiac function in CX3CR1-/- CVB3 mice versus
WT CVB3 mice might be the increased apoptosis of cardiomyocytes, as suggested by the
higher Bax/Bcl-2 ratio in CX3CR1-/- CVB3 versus WT CVB3 mice [29]. Overall, cardiac func-
tion was determined with a tip catheter. In contrast to a non-invasive method as echocardiog-
raphy, this method only allows the measurement at a single time point, which is hence a
limitation of the study.
Conclusion
Our observations allow us to conclude that CX3CR1 emerges to be cardioprotective in the
pathogenesis of CVB3-induced myocarditis since CX3CR1-/- mice were more susceptible to
CVB3 infection as WT animals. A functional CX3CR1 seems to be critical for the control of
MCP-1/CCR2-mediated inflammatory cell invasion and the related inflammatory response,
apoptosis, and CVB3 presence. Nevertheless, other studies demonstrated a controversial role
of CX3CR1, which emphasizes the complexity of the CX3CL1/CX3CR1 system and its poten-
tial difference depending on the pathogenic disorder. Finally, we conclude that the modulation
of the CX3CL1/CX3CR1 axis could be a new important target in the treatment of CVB3-in-
duced myocarditis.
Supporting information
S1 Fig. CX3CL1-expressing cells in the left ventricle of mice. Representative pictures of
immunohistological stainings on successive tissue samples from LV (A) CD68+ cells (left pic-
ture) and CX3CL1 (right picture), (B) CD11b+ cells (left picture) and CX3CL1 (right picture),
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(C) Ly6G+ cells (left picture) and CX3CL1 (right picture), (D) CD4+ cells (left picture) and
CX3CL1 (right picture), (E) CD8a+ cells (left picture) and CX3CL1 (right picture), and (F) FB
(fibroblast)-marker+ cells (left picture) and CX3CL1 (right picture) using a 200x magnifica-
tion. Arrows highlight overlapping areas. WT = wild-type; CVB3 = Coxsackievirus B3.
(TIF)
S2 Fig. Regulation of chemokine receptors and the corresponding chemokines in the
spleen of Coxsackievirus B3-infected mice. Bar graphs represent the mean ± SEM of splenic
(A) CCR2, (B) MCP-1, (C) CX3CR1, and (D) CX3CL1 gene expression, as indicated, after nor-
malization to the housekeeping gene 18S using the 2−ΔCt formula and normalized to the WT
group, which was set as 1. Statistical analysis was performed by One-way ANOVA or the Krus-
kal-Wallis test. p<0.05, p<0.01, p<0.001 with n = 7–12 per group.
(TIF)
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